Biohacker Bryan Johnson Diagnosed With 'Incurable' Autoimmune Gastritis

For a man who spends $2 million a year to reverse his biological age, the announcement was a stark reminder of human vulnerability. In early July 2026, tech entrepreneur and longevity advocate Bryan Johnson revealed that he had been diagnosed with autoimmune gastritis (AIG), a chronic and currently incurable condition.[1]

Johnson, 48, is famous for "Project Blueprint," an exhaustive regimen of constant biometric monitoring, strict diets, and experimental therapies designed to halt the aging process. Yet, despite being arguably the most measured human alive, a silent disease had been progressing inside his body for years.[2]

"My stomach is eating itself," Johnson wrote in a social media post detailing the diagnosis. While his phrasing was dramatic, the underlying medical reality highlights a complex intersection between extreme health monitoring, the limits of current biohacking, and the stubborn nature of autoimmune diseases.[1]

The path to Johnson's diagnosis began with a single, stubborn biomarker: ferritin. Ferritin is a protein that stores iron inside cells, and Johnson's medical team noticed that his levels remained persistently low despite his meticulously planned diet and oral iron supplements.[2]

Because Johnson did not exhibit classic symptoms of anemia—such as severe fatigue or weakness—the iron deficiency was a quiet red flag. His team initiated a comprehensive medical workup to find the source of the disappearing iron, starting with a colonoscopy to rule out internal bleeding or colon cancer, which came back clear.

The search then moved to his upper gastrointestinal tract. An endoscopy and five biopsies taken from three different regions of his stomach finally revealed the culprit. Blood work confirmed the presence of elevated anti-parietal cell antibodies, cementing the diagnosis of early-stage autoimmune gastritis.[1]

Autoimmune gastritis is fundamentally a case of mistaken identity by the body's defense system. In a healthy stomach, specialized cells called parietal cells secrete hydrochloric acid to break down food and produce "intrinsic factor," a protein essential for the absorption of vitamin B12.

In patients with AIG, the immune system produces autoantibodies that mistakenly attack and destroy these parietal cells. As the cells are wiped out, the stomach loses its ability to produce acid and intrinsic factor. This condition is entirely distinct from the more common H. pylori gastritis, which is driven by a bacterial infection.

The destruction of parietal cells explains Johnson's mysterious iron deficiency. Stomach acid is required to convert dietary iron into a form the body can absorb in the intestines. Without it, iron simply passes through the digestive tract, eventually leading to depleted stores and, if left unchecked, severe anemia and neurological issues from B12 deficiency.

The diagnosis also carries long-term risks. The chronic inflammation and cellular damage associated with AIG can cause irreversible atrophy of the stomach lining, significantly increasing the risk of developing gastric cancer over time.[1]

While Johnson speculated that his childhood diet of sugary cereals and a highly stressful decade in his twenties might have triggered the disease, medical experts point to a much clearer culprit: his own medical history.[1]

At age 21, Johnson was diagnosed with autoimmune hypothyroidism, a condition where the immune system attacks the thyroid gland. Research shows that autoimmune diseases frequently cluster together. According to the Global Autoimmune Institute, patients with one autoimmune condition are at a significantly higher risk of developing another, as the immune system is already primed to misfire.

In fact, clinical studies have found that more than half of patients with autoimmune gastritis also have an associated thyroid disorder. For gastroenterologists, Johnson's progression from autoimmune thyroid disease to autoimmune gastritis is a well-documented biological pathway, rather than a failure of his recent lifestyle choices.

The revelation has sparked a clash of paradigms regarding how to handle chronic illness. Standard medical care for AIG focuses on symptom management and surveillance. Patients receive intravenous iron infusions—which Johnson has already begun—along with B12 injections, and undergo regular endoscopies to monitor for cancerous changes.

Johnson, however, has publicly rejected this approach. "When AIG is discovered today, standard medical care concedes defeat," he wrote, declaring his intention to "solve" the condition using artificial intelligence, multiomics, and custom-built genetic therapies.[1]

Medical professionals caution that while the future of autoimmune treatment is promising, curing AIG remains highly experimental. Emerging research is exploring microbiome-based therapies and ways to restore immune tolerance, but these approaches are not yet available in clinical practice.

Ultimately, Johnson's diagnosis offers a profound lesson for the longevity movement. It demonstrates that no amount of money or measurement can entirely override genetic predispositions or the complex realities of human biology.

Yet, it also validates the core premise of proactive medicine. Because Johnson was monitoring his ferritin levels so closely, the disease was caught in its early stages, long before it caused severe anemia or progressed to cancer. In the end, his extreme protocol may not have prevented the disease, but it successfully prevented the disease from remaining a silent threat.[2]